ASP7374: Phase III ongoing

Astellas and UMN Pharma said all subjects were vaccinated in an open-label, Japanese Phase III trial evaluating intramuscular ASP7374.

Read the full 191 word article

How to gain access

Continue reading with a
two-week free trial.